You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings

    SBC: LIFEGENE- BIOMARKS, INC            Topic: 102

    Project Summary A diagnosis of Head and neck squamous cell carcinoma (HNSCC) includes many cancer subtypes. We will focus on the oral cavity squamous cell carcinoma (OSCC) subtype on the proposed project. OSCC is the 11th most common malignancy in the world. Despite advances in treatments, the 5-year survival rates for OSCC have not improved for the past 25 years. OSCC is a very aggressive tumor, ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Innovative technology for elimination of microbubbles during hemodialysis treatments

    SBC: SIL Technologies LLC            Topic: 400

    Project Summary Around 400,000 patients in the US and at least 5 million world-wide, receive weekly sessions of hemodialysis (HD), the standard long-term treatment for irreversible kidney failure. Although it has revolutionized the field by increasing the longevity of patients, improvements in the technique and equipment have been stagnant for decades. Besides from still suffering from high premat ...

    SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  3. Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America

    SBC: LIFEGENE- BIOMARKS, INC            Topic: 102

    Project Summary No woman should die from cervical cancer. We have the technical, medical and policy tools and approaches to eliminate it. Yet, one woman dies of cervical cancer every two minutes. Cervical cancer is the third leading malignancy among women in the world, after breast and colorectal cancer. Cervical cancer is also one of the tumors in which the most glaring disparities exist worldwid ...

    SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  4. Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America

    SBC: LIFEGENE- BIOMARKS, INC            Topic: 102

    Project Summary No woman should die from cervical cancer. We have the technical, medical and policy tools and approaches to eliminate it. Yet, one woman dies of cervical cancer every two minutes. Cervical cancer is the third leading malignancy among women in the world, after breast and colorectal cancer. Cervical cancer is also one of the tumors in which the most glaring disparities exist worldwid ...

    SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  5. Precision methylation biomarkers linked to cancer disparities

    SBC: LIFEGENE- BIOMARKS, INC            Topic: 102

    Project Summary No woman should die of cervical cancer, yet cervical cancer is the third leading malignancy among women in the world, after breast cancer and colorectal cancer. Cervical cancer is also one of the tumors in which the most glaring disparities exist worldwide. Cervical cancer incidence and mortality has been higher for decades among Latinas in the United States (US). However, a recent ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  6. Precision methylation biomarkers linked to cancer disparities

    SBC: LIFEGENE- BIOMARKS, INC            Topic: 102

    Project Summary No woman should die of cervical canceryet cervical cancer is the third leading malignancy among women in the worldafter breast cancer and colorectal cancerCervical cancer is also one of the tumors in which the most glaring disparities exist worldwideCervical cancer incidence and mortality has been higher for decades among Latinas in the United StatesUSHowevera recently published st ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. CranialProgrammer: Image-Guided Directional Deep Brain Stimulation Programming Using Local-Field Potentials

    SBC: Nexeon Medsystems Puerto Rico Operating Company Inc            Topic: 105

    ABSTRACT The goal of this Uproposal is to develop and test CranialProgrammeran image guided programming tool forDD mapping of disease related neural signals over patient and device data for more efficient and effective programming of directional deep brain stimulationDBSsystemsDBS is an established treatment for advancedrefractory movement disorders used in overpatientsHowevermany patients receive ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Innovative therapy for accelerated recovery of decompression sickness patients

    SBC: SIL Technologies LLC            Topic: NHLBI

    PROJECT SUMMARY There are aroundemergency room admissions annually in the US due to scuba injuriesFrom thosearoundrelate to Decompression SicknessDCSa condition developed when nitrogen dissolved in blood and tissues at high pressure forms bubbles as pressure decreasesTreatment for DCS is recompression in hyperbaric chambersfollowing slow and controlled normalization of pressure conditionsEarly int ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Validation of immune-based biomarkers for endometriosis.

    SBC: CDI LABORATORIES, INC            Topic: NICHD

    ABSTRACT Endometriosis is a highly prevalent gynecologic disease characterized by severe pelvic pain and infertility that negatively impacts the wellbeing and quality of life of millions of women worldwide Despite decades of basic and clinical research on endometriosis there is limited understanding of its pathophysiology and no specific non invasive diagnostic assays are available ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Monospecific monoclonal antibodies against human protein complexes on an interactome-wide scale.

    SBC: CDI LABORATORIES, INC            Topic: NCI

    Project Summary Antibodies can facilitate the study of associations between different proteins in the cell using a technique known as immunoprecipitation IP This approach can reveal differences in protein associations present in healthy vs diseased tissues provide targets for diagnostics and therapeutics and reveal protein protein interfaces that could be druggab ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government